Research Roundup

Debbie Rigby 13/05/2025

Debbie Rigby rounds up the latest in research news Combination of Glucagon-Like Peptide 1 Receptor Agonist and Thiazolidinedione for Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes In this cohort study of 220 822 patients with type 2 diabetes, combination therapy with a GLP-1RA and thiazolidinedione was associated with significantly lower hazards of all-cause

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Research Roundup

Previous What's coming up on the calendar?

Next Businesses need to ‘step up’ data security: OAIC

MENU

ajp.com.au

Previous What's coming up on the calendar?

Next Businesses need to ‘step up’ data security: OAIC

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.